Search filters

List of works by Tim Clackson

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

scientific article

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients

scientific article

Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study

scientific article published on 21 May 2013

Ponatinib in refractory Philadelphia chromosome-positive leukemias

scientific article

Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies

scientific article published on 11 April 2011

Paulina is supported by:

About Paulina

Help